Biomaterials Market Research Report Information By Type (Metallic, Ceramics, Polymeric and Natural Biomaterials), By Application (Joint Replacements, Ophthalmology, Cardiovascular, Wound Healing, Plastic Surgery and Neurological Conditions), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Application

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL BIOMATERIALS MARKET, BY TYPE

6.1. Overview

6.2. Metallic

6.2.1. Stainless Steel

6.2.2. Titanium & Titanium Alloys

6.2.3. Cobalt-Chrome Alloys

6.2.4. Silver

6.2.5. Gold

6.2.6. Magnesium

6.2.7. Others

6.3. Ceramics

6.3.1. Calcium Phosphate

6.3.2. Aluminum Oxide

6.3.3. Zirconia

6.3.4. Calcium Sulfate

6.3.5. Carbon

6.3.6. Glass

6.3.7. Others

6.4. Polymeric

6.4.1. Polymethylmethacrylate (PMMA)

6.4.2. Polyethylene

6.4.3. Polyester

6.4.4. Polyvinyl Chloride

6.4.5. Silicone Rubber

6.4.6. Nylon

6.4.7. Polyetheretherketone (PEEK)

6.4.8. Others

6.5. Natural Biomaterials

6.5.1. Hyaluronic Acid

6.5.2. Collagen

6.5.3. Gelatin

6.5.4. Fibrin

6.5.5. Cellulose

6.5.6. Chitin

6.5.7. Alginate

6.5.8. Others

7. GLOBAL BIOMATERIALS MARKET, BY APPLICATION

7.1. Overview

7.2. Joint Replacements

7.3. Ophthalmology

7.4. Cardiovascular

7.5. Wound Healing

7.6. Plastic Surgery

7.7. Neurological Conditions

7.8. Others

8. GLOBAL BIOMATERIALS MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the global biomaterials market

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the global biomaterials market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2021

9.8.2. Major Players R&D Expenditure. 2021

10. COMPANY PROFILES

10.1. Royal DSM

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. BASF SE

10.3. Corbion N.V.

10.4. Covestro

10.5. Invibio Ltd.

10.6. Carpenter Technology Corporation

10.7. Evonik Industries AG

10.8. Berkeley Advanced Biomaterials, Inc.

10.9. CAM Bioceramics BV

10.10. Celanese Corporation

10.11. Wright Medical Technology, Inc.

10.12. Zimmer Biomet Holdings, Inc.

10.13. Bayer AG

10.14. Collagen Matrix

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL BIOMATERIALS MARKET SYNOPSIS, 2022–2030

TABLE 2 GLOBAL BIOMATERIALS MARKET ESTIMATES & FORECAST, 2022–2030 (USD MILLION)

TABLE 3 GLOBAL BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 4 GLOBAL BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL BIOMATERIALS MARKET, BY END USE, 2022–2030 (USD MILLION)

TABLE 6 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: BIOMATERIALS MARKET, BY END USE, 2022–2030 (USD MILLION)

TABLE 10 US: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 11 US: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 12 US: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 13 US: BIOMATERIALS MARKET, BY END USE, 2022–2030 (USD MILLION)

TABLE 14 CANADA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 15 CANADA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 16 CANADA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 17 CANADA: BIOMATERIALS MARKET, BY END USE, 2022–2030 (USD MILLION)

TABLE 1 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 2 EUROPE: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 3 EUROPE: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 4 EUROPE: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 5 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 6 GERMANY: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 7 GERMANY: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 8 GERMANY: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 9 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 10 FRANCE: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 11 FRANCE: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 12 FRANCE: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 13 ITALY: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 14 ITALY: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 15 ITALY: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 16 ITALY: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 17 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 18 SPAIN: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 19 SPAIN: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 20 SPAIN: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 21 UK: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 22 UK: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 23 UK: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 24 UK: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 25 REST OF EUROPE: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 26 REST OF EUROPE: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 27 REST OF EUROPE: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 28 REST OF EUROPE: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 29 ASIA-PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 30 ASIA-PACIFIC: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 31 ASIA-PACIFIC: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 32 ASIA-PACIFIC: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 33 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 34 JAPAN: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 35 JAPAN: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 36 JAPAN: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 37 CHINA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLIXON)

TABLE 38 CHINA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 39 CHINA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 40 CHINA: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 41 INDIA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 42 INDIA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 43 INDIA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 44 INDIA: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 45 AUSTRALIA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 46 AUSTRALIA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 47 AUSTRALIA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 48 AUSTRALIA: BIOMATERIALS MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 49 SOUTH KOREA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 50 SOUTH KOREA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 51 SOUTH KOREA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 52 SOUTH KOREA: BIOMATERIALS MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 53 REST OF ASIA-PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 54 REST OF ASIA-PACIFIC: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 55 REST OF ASIA-PACIFIC: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 56 REST OF ASIA-PACIFIC: BIOMATERIALS MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 57 REST OF THE WORLD: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 58 REST OF THE WORLD: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 59 REST OF THE WORLD: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 60 REST OF THE WORLD: BIOMATERIALS MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 61 MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 62 MIDDLE EAST: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 63 MIDDLE EAST: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 64 MIDDLE EAST: BIOMATERIALS MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 65 AFRICA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 66 AFRICA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 67 AFRICA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 68 AFRICA: BIOMATERIALS MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 69 LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 70 LATIN AMERICA: BIOMATERIALS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 71 LATIN AMERICA: BIOMATERIALS MARKET, BY CHROMATOGRAPHY TYPE, 2022–2030 (USD MILLION)

TABLE 72 LATIN AMERICA: BIOMATERIALS MARKET, END USER, 2022–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIOMATERIALS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIOMATERIALS MARKET

FIGURE 4 GLOBAL BIOMATERIALS MARKET SHARE, BY TYPE, 2021 (%)

FIGURE 5 GLOBAL BIOMATERIALS MARKET SHARE, BY PRODUCT, 2021 (%)

FIGURE 6 GLOBAL BIOMATERIALS MARKET SHARE, BY CHROMATOGRAPHY TYPE, 2021(%)

FIGURE 7 GLOBAL BIOMATERIALS MARKET SHARE, BY END USER, 2021(%)

FIGURE 8 GLOBAL BIOMATERIALS MARKET SHARE, BY REGION, 2021 (%)

FIGURE 9 NORTH AMERICA: BIOMATERIALS MARKET SHARE, BY REGION, 2021 (%)

FIGURE 10 EUROPE: BIOMATERIALS MARKET SHARE, BY REGION, 2021 (%)

FIGURE 11 ASIA-PACIFIC: BIOMATERIALS MARKET SHARE, BY REGION, 2021 (%)

FIGURE 12 REST OF THE WORLD: BIOMATERIALS MARKET SHARE, BY REGION, 2021 (%)

FIGURE 13 GLOBAL BIOMATERIALS MARKET: COMPANY SHARE ANALYSIS, 2021 (%)

FIGURE 14 ROYAL DSM: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ROYAL DSM: SWOT ANALYSIS

FIGURE 16 BASF SE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 BASF SE: SWOT ANALYSIS

FIGURE 18 CORBION N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 CORBION N.V.: SWOT ANALYSIS

FIGURE 20 COVESTRO: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 COVESTRO: SWOT ANALYSIS

FIGURE 22 INVIBIO LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 INVIBIO LTD.: SWOT ANALYSIS

FIGURE 24 CARPENTER TECHNOLOGY CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 CARPENTER TECHNOLOGY CORPORATION: SWOT ANALYSIS

FIGURE 26 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 EVONIK INDUSTRIES AG: SWOT ANALYSIS

FIGURE 28 BERKELEY ADVANCED BIOMATERIALS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 BERKELEY ADVANCED BIOMATERIALS, INC.: SWOT ANALYSIS

FIGURE 30 CAM BIOCERAMICS BV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 CAM BIOCERAMICS BV: SWOT ANALYSIS

FIGURE 32 CELANESE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 CELANESE CORPORATION: SWOT ANALYSIS

FIGURE 34 WRIGHT MEDICAL TECHNOLOGY, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 WRIGHT MEDICAL TECHNOLOGY, INC.: SWOT ANALYSIS

FIGURE 36 ZIMMER BIOMET HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 ZIMMER BIOMET HOLDINGS: SWOT ANALYSIS

FIGURE 38 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 BAYER AG: SWOT ANALYSIS

FIGURE 40 COLLAGEN MATRIX: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 COLLAGEN MATRIX: SWOT ANALYSIS